What question did this study set out to answer?

To examine guideline-to-practice care gaps in post-acute coronary syndrome dyslipidemia management, identify opportunities for therapy intensification, and assess reasons for underprescribing recommended lipid-lowering treatments.

January 1, 2024CardiologyOpen Access

Optimizing Post-Acute Coronary Syndrome Dyslipidemia Management: Insights from the North American Acute Coronary Syndrome Reflective III

Q: What is the clinical evidence from this study?

Study design: Observational. Population: Post-Acute Coronary Syndrome Dyslipidemia (n=248). Intervention: Individual patient and aggregate practice feedback on guideline-recommended lipid-lowering therapy vs. Baseline (pre-intervention). Primary outcome: Achievement of guideline-recommended LDL-C thresholds at 6-12 months (Visit 3) (p=0.0244).

View Full Paper

Ask AI

Bookmark

Key result

Providing individual patient and aggregate practice feedback to physicians increased the proportion of post-ACS patients achieving guideline-recommended LDL-C thresholds from 0% at baseline to 53.4% at 6-12 months.

Why the study?

Despite contemporary guidelines, many post-ACS patients fail to achieve recommended LDL-C thresholds, motivating an investigation into the care gap, opportunities for lipid-lowering therapy escalation, and reasons for non-prescription.

Does physician feedback improve the achievement of guideline-recommended LDL-C thresholds in post-ACS patients?

Population

248 post-ACS patients with LDL-C ≥1.81 mmol/L (70 mg/dL) despite maximally tolerated statin ± ezetimibe

Comparison

Individual and aggregate practice feedback on guideline-recommended intensification provided to physicians

Design

Multicenter pilot study across 27 Canadian and US sites

Follow-up

12 months post-event

Authors

MAMeshal AlaneziUniversity of Toronto AYAndrew T. YanCardiac Imaging MTMary TanSt. Michael's Hospital

Discussion

Member takes

Implication

Persistent LDL-C gaps post-ACS may prompt therapy review; leaves open targeted strategies to close care gaps in larger studies.

Key Points

To examine guideline-to-practice care gaps in post-acute coronary syndrome dyslipidemia management, identify opportunities for therapy intensification, and assess reasons for underprescribing recommended lipid-lowering treatments.
Enrolled 248 post-acute coronary syndrome patients (median age 64 years; 31.5% female; 27.4% STEMI) across 27 Canadian and US sites between September 2018 and October 2020.
Included patients with LDL-C ≥1.81 mmol/L (70 mg/dL) despite maximally tolerated statin therapy with or without ezetimibe (or intolerance to ≥2 statins), tracking outcomes across three visits over 12 months.
Provided participating physicians with individual patient and aggregate practice feedback, including recommendations for guideline-directed lipid-lowering therapy intensification.
At baseline, 75.4% of patients were taking high-intensity statins, but 0% had achieved guideline-recommended LDL-C thresholds.
Following physician feedback, ezetimibe and PCSK9 inhibitor prescriptions increased, reducing mean LDL-C from 2.93 mmol/L at baseline to 2.09 mmol/L at 3–6 months and 1.87 mmol/L at 6–12 months.
The proportion of patients achieving guideline LDL-C thresholds increased to 38.6% at 3–6 months and 53.4% at 6–12 months, though non-intensification persisted due to near-target levels, existing therapies, patient refusal, and drug cost.

Study Design

Type

Observational (n=248)

Multicenter

Yes

Structured PICO

Does physician feedback improve the achievement of guideline-recommended LDL-C thresholds in post-ACS patients?

Population

248 post-acute coronary syndrome patients with elevated LDL-C despite maximally tolerated statin therapy, followed for 12 months to assess the impact of physician feedback on guideline-directed lipid-lowering therapy optimization.

Intervention

Individual patient and aggregate practice feedback, including guideline-recommended intensification suggestions, provided to each physician.

Outcome

Proportion of patients achieving Canadian/US guideline-recommended LDL-C thresholds, eligibility for additional lipid-lowering therapies, and reasons behind lack of escalation in lipid-lowering therapies.surrogate

Main Result

Absolute Event Rate: 53.4% vs 0%

p-value: p=0.0244

Providing individual and aggregate practice feedback to physicians improves the intensification of lipid-lowering therapies and the achievement of LDL-C targets in post-ACS patients.

Limitations

Small sample size from 27 North American sites, which may not be fully representative of post-ACS dyslipidemia care in Canada and the USA.
The true number of patients who achieved threshold LDL-C levels might not have been adequately captured since many patients had no repeat LDL-C levels as part of routine care.
Physicians choosing to participate were likely more interested in quality improvement, meaning their patient management might not be a true reflection of general care and results might not be generalizable.

Cite This Study

Alanezi et al. (2024) conducted an observational in Post-Acute Coronary Syndrome Dyslipidemia (n=248). Individual patient and aggregate practice feedback on guideline-recommended lipid-lowering therapy vs. Baseline (pre-intervention) was evaluated on Achievement of guideline-recommended LDL-C thresholds at 6-12 months (Visit 3) (p=0.0244). Providing individual patient and aggregate practice feedback to physicians increased the proportion of post-ACS patients achieving guideline-recommended LDL-C thresholds from 0% at baseline to 53.4% at 6-12 months.

synapsesocial.com/papers/6a9f70488c462a8aba107e2b https://doi.org/10.1159/000536392

Topics

Statin therapy Lipid management

View Full Paper

Ask AI

Bookmark

Optimizing Post-Acute Coronary Syndrome Dyslipidemia Management: Insights from the North American Acute Coronary Syndrome Reflective III

Discussion

Member takes

Implication

Key Points

Study Design

Structured PICO

Main Result

Limitations

Cite This Study

Topics

Optimizing Post-Acute Coronary Syndrome Dyslipidemia Management: Insights from the North American Acute Coronary Syndrome Reflective III

Discussion

Member takes

Implication

Key Points

Study Design

Structured PICO

Main Result

Limitations

Cite This Study

Also Consider

Topics

Also Consider